DrugBiological
VAK694 clinical trials
Also written VAK694.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2009 (2)
| Year | Studies |
|---|---|
| 2009 | 2 |
| 2010 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses VAK694 is read from its arms, and is right about nine times in ten.
Testing it · 3
- To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With AsthmaCompletedPhase 1Novartis PharmaceuticalsNCT01568762Written as VAK694
- Safety, Tolerability and Pharmacokinetics of Multiple Doses of VAK694 in Atopic Subjects With Seasonal RhinitisCompletedPhase 2Novartis PharmaceuticalsNCT00929968Written as VAK694
- A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune ToleranceCompletedPhase 2Novartis PharmaceuticalsNCT01018693Written as VAK694; Alutard Avanz SQ